BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 25, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 2, 2018
View Archived Issues
ANI Pharmaceuticals acquires NDAs, U.S. rights to four AstraZeneca products
Read More
CStone Pharmaceuticals announces IND filing in Australia
Read More
FDA clears Ignyta's IND for RXDX-106 study
Read More
Wanbang Biopharmaceuticals submits IND in China for SGLT2 inhibitor
Read More
FDA accepts Progenics' Azedra NDA for review
Read More
Siglec-7 targeting shows promise against multiple myeloma
Read More
Galapagos and Servier report ADAMTS inhibitors for osteoarthritis
Read More
CXCL12 shown to impact tipifarnib benefit in AML and MDS patients
Read More
Oncimmune signs framework agreement with Genostics for EarlyCDT platform in China
Read More
Vitae Pharmaceuticals patents Menin/MLL interaction inhibitors
Read More
GABA(A) receptor agonists reported in Sichuan Haisco Pharmaceutical patent
Read More
Phase III study of EG-1962 in aneurysmal subarachnoid hemorrhage recommended to continue
Read More
Universita del Piemonte Orientale prepares and tests CRAC modulators
Read More
GlaxoSmithKline patents describe ATF4 inhibitors
Read More
Atara cleared to begin phase III studies of tabelecleucel
Read More
Servier and Vernalis jointly patent USP7 inhibitors
Read More
ImmunoPrecise Antibodies invests in SERPINx to develop serine protease inhibitors
Read More
SELLAS Life Sciences Group completes merger with Galena Biopharma
Read More
Bio-Path updates pipeline progress
Read More
Global Foundation for Human Aging Research funds research at Dana-Farber into cellular aging
Read More
PHF2 expression impacts survival of ALL patients
Read More
